Triazolopyridazine derivatives as selective and orally bioavailable c-Met inhibitors

被引：0

作者：

Romero, Karina ^{[1
]}

Bauer, David ^{[1
]}

Bellon, Steve ^{[2
]}

Berry, Loren M. ^{[3
]}

Bode, Christiane ^{[1
]}

Boezio, Alessandro ^{[1
]}

Broome, Martin ^{[4
]}

Choquette, Deborah ^{[1
]}

Chen, April ^{[3
]}

Dussault, Isabelle ^{[4
]}

Huang, Liyue ^{[3
]}

Kaplan-Lefko, Paula ^{[4
]}

Lewis, Richard ^{[1
]}

Lin, Jasmine ^{[3
]}

Lohman, Julia ^{[1
]}

Potashman, Michele ^{[1
]}

Rex, Karen ^{[4
]}

Shah, Kavitah ^{[5
]}

Shimanovich, Roman ^{[5
]}

Teffera, Yohannes ^{[3
]}

Yang, Yajing ^{[4
]}

Zhang, Michael ^{[4
]}

Zhao, Zhiyang ^{[4
]}

Harmange, Jean-Claude ^{[1
]}

机构：

[1] Amgen Inc, Dept Med Chem, Cambridge, MA 02139 USA

[2] Amgen Inc, Dept Mol Struct, Cambridge, MA 02139 USA

[3] Amgen Inc, Dept Pharmacokinet & Drug Metab, Cambridge, MA 02139 USA

[4] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA

[5] Amgen Inc, Dept Small Mol Prod Dev, Cambridge, MA 02139 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

136-MEDI

引用

页数：1

共 50 条

[1] Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors
Boezio, Alessandro A.
Berry, Loren
Albrecht, Brian K.
Bauer, David
Bellon, Steven F.
Bode, Christiane
Chen, April
Choquette, Deborah
Dussault, Isabelle
Hirai, Satoko
Kaplan-Lefko, Paula
Larrow, Jay F.
Lin, Min-Hwa Jasmine
Lohman, Julia
Potashman, Michele H.
Rex, Karen
Santostefano, Michael
Shah, Kavita
Shimanovich, Roman
Springer, Stephanie K.
Teffera, Yohannes
Yang, Yajing
Zhang, Yihong
Harmange, Jean-Christophe
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (22) : 6307 - 6312
[2] Selective and Orally Bioavailable c-Met PROTACs for the Treatment of c-Met-Addicted Cancer
Ying, Shilong
Chi, Hongli
Wu, Xiaoqiu
Zeng, Pingping
Chen, Jinling
Fu, Ting
Fu, Weitao
Zhang, Penghui
Tan, Weihong
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (19) : 17053 - 17069
[3] Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors (vol 19, pg 6307, 2009)
Boezio, Alessandro A.
Berry, Loren
Albrecht, Brian K.
Bauer, David
Bellon, Steven F.
Bode, Christiane
Chen, April
Choquette, Deborah
Dussault, Isabelle
Fang, Mei
Hirai, Satoko
Kaplan-Lefko, Paula
Larrow, Jay F.
Lin, Min-Hwa Jasmine
Lohman, Julia
Potashman, Michele H.
Qu, Yusheng
Rex, Karen
Santostefano, Michael
Shah, Kavita
Shimanovich, Roman
Springer, Stephanie K.
Teffera, Yohannes
Yang, Yajing
Zhang, Yihong
Harmange, Jean-Christophe
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 773 - 773
[4] Triazolopyridazine derivatives: Synthesis, cytotoxic evaluation, c-Met kinase activity and molecular docking
Ahmed, Eman M.
Khalil, Nadia A.
Taher, Azza T.
Refaey, Rana H.
Nissan, Yassin M.
BIOORGANIC CHEMISTRY, 2019, 92
[5] Synthesis of triazolotriazine derivatives as c-Met inhibitors
Yuting Guo
Xia Peng
Yinchun Ji
Yitong Zhang
Jian Ding
Zhengsheng Zhan
Jing Ai
Wenhu Duan
Molecular Diversity, 2021, 25 : 839 - 846
[6] Synthesis of triazolotriazine derivatives as c-Met inhibitors
Guo, Yuting
Peng, Xia
Ji, Yinchun
Zhang, Yitong
Ding, Jian
Zhan, Zhengsheng
Ai, Jing
Duan, Wenhu
MOLECULAR DIVERSITY, 2021, 25 (02) : 839 - 846
[7] Identification of orally active small molecule c-met inhibitors
Miknyoczki, Sheila
Underiner, Ted
Aimone, Lisa
Chang, Hong
Galinis, Debbie
Grobelny, Jennifer
Hebertz, Torsten
Huang, Zeqi
Husten, Jean
Mikiewicz, Karen
Murthy, Seetha
Pritchard, Sonya
Weinberg, Linda
Worrell, Candace
Ator, Mark
Dorsey, Bruce
Ruggeri, Bruce
CANCER RESEARCH, 2009, 69
[8] c-Met inhibitors
Mughal, Anum
Aslam, Hafiz Muhammad
Sheikh, Asfandyar
Khan, Agha Muhammad Hammad
Saleem, Shafaq
INFECTIOUS AGENTS AND CANCER, 2013, 8
[9] C-MET INHIBITORS
Adjei, A. A.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S22 - S22
[10] c-Met inhibitors
Anum Mughal
Hafiz Muhammad Aslam
Asfandyar Sheikh
Agha Muhammad Hammad Khan
Shafaq Saleem
Infectious Agents and Cancer, 8

← 1 2 3 4 5 →